The patient is central to everything we do day-to-day. Often if they are using one of our niche or unlicensed medicines it is because they have failed to respond to front line therapies or have a rare or difficult to treat condition. Shortages and delays can be life-threatening. In a similar way, if a comparator medicine is unavailable for a clinical trial, progress in developing new treatments can be significantly delayed. We don’t just help make medicines available, we get them to the people who need them all over the world and however challenging the circumstances.